Subscribe

NIOX Group Plc (CSSPF)

USD0.75 +0.00 (+0.00%)
GB OTC Healthcare Medical - Care Facilities
Address Magdalen Centre OX4 4GA
Oxford, WA, GB
CEO Jonathan Emms
Website niox.com
IPO 2020-02-03
ISIN GB00BJVD3B28

Explore sections of this company profile

Also trades on London Stock Exchange · CIR.L (GBp) London Stock Exchange · NIOX.L (GBp) Other OTC · CSSPF (USD)
Description

Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.75 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
28
Beta
-0.06
Float Shares
329.25M
Free Float %
78.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.00% -13.08% -13.08% -13.08% +15.89% +66.59% +73.84% +105.04% +105.04%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (1 ratings, all time) Hold
Price Targets & DCF
Current price
0.75
DCF (Unlevered) 1.64 +118.8%
DCF (Levered) 2.32 +209.7%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Quality scores
Altman Z-Score
20.65
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
7 / 10
Strong MOAT
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +16.5% ★ Q4'25: +30.5% (vs Q4'23)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +97.6% ★ Q4'25: -82.2% (vs Q4'23)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +12.1% Q4'25: +36.6% (vs Q4'23)
  • ✓
    EBIT margin Medical - Care Facilities: +11.3%
    +22.0% ★ Q4'25: +20.9% (vs Q4'23)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +13.7% ★ Q4'25: +24.1% (vs Q4'23)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    -4.9% ★ Q4'25: -5.8% (vs Q4'23)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.09× ★ Q4'25: 0.05× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.04) × ERP
WACC = 100% × Ke + 0% × Kd (20.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 1.64 Current price: 0.75
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
5 Rev. Ana.
1 EPS Ana. 		Dec 2027
5 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
10.80M
est: 14.64M (-26.2%)
23.10M
est: 30.37M (-23.9%)
46.30M
est: 62.72M (-26.2%)
48.30M
est: 62.53M (-22.8%)
34.60M
est: 82.66M (-58.1%)
23.90M
est: 35.54M (-32.8%)
27.90M
est: 37.72M (-26.0%)
31.30M
est: 37.85M (-17.3%)
36.80M
est: 46.85M (-21.4%)
41.80M
est: 41.79M (+0.0%)
48.69M
est: 48.69M (+0.0%)
50.24M
49.06M – 51.26M
+3.2% YoY
54.32M
52.98M – 55.35M
+8.1% YoY
57.37M
55.99M – 58.49M
+5.6% YoY
EBITDA
-64.60M
est: 81.7K (-79,198.8%)
-33.50M
est: 169.4K (-19,879.6%)
-66.60M
est: 349.8K (-19,137.7%)
-32.80M
est: 348.8K (-9,504.2%)
-14.90M
est: 461.1K (-3,331.7%)
-9.30M
est: 198.2K (-4,791.6%)
2.90M
est: 210.4K (+1,278.6%)
15.20M
est: 805.2K (+1,787.7%)
8.60M
est: 996.5K (+763.0%)
12.10M
est: 11.14M (+8.7%)
10.70M
est: 12.98M (-17.6%)
13.39M
13.07M – 13.66M
+3.2% YoY
14.48M
14.12M – 14.75M
+8.1% YoY
15.29M
14.92M – 15.59M
+5.6% YoY
EBIT
-67.50M
est: -3.60M (-1,773.7%)
-38.80M
est: -7.47M (-419.3%)
-71.50M
est: -15.43M (-363.3%)
-43.90M
est: -15.39M (-185.3%)
-27.50M
est: -20.34M (-35.2%)
-18.30M
est: -8.74M (-109.3%)
-2.00M
est: -9.28M (+78.4%)
10.60M
est: -8.15M (+230.1%)
4.20M
est: -10.09M (+141.6%)
7.90M
est: 6.60M (+19.7%)
10.70M
est: 7.69M (+39.1%)
7.94M
7.75M – 8.10M
+3.2% YoY
8.58M
8.37M – 8.74M
+8.1% YoY
9.06M
8.84M – 9.24M
+5.6% YoY
Net Income
-49.90M
est: -157.16M (+68.2%)
-137.30M
est: -181.77M (+24.5%)
-99.10M
est: -146.47M (+32.3%)
-117.10M
est: -53.53M (-118.7%)
-48.30M
est: -55.95M (+13.7%)
-33.50M
est: -23.95M (-39.9%)
3.60M
est: 4.19M (-14.1%)
16.10M
est: 9.10M (+76.9%)
10.70M
est: 10.45M (+2.3%)
3.70M
est: 12.36M (-70.1%)
7.00M
est: 10.84M (-35.4%)
13.50M
13.08M – 13.84M
+24.5% YoY
15.25M
14.77M – 15.64M
+13.0% YoY
14.93M
14.46M – 15.31M
-2.1% YoY
SGA
27.20M
est: 7.87M (+245.5%)
41.60M
est: 16.32M (+154.8%)
59.90M
est: 33.72M (+77.6%)
65.80M
est: 33.62M (+95.7%)
38.20M
est: 44.44M (-14.0%)
26.80M
est: 19.11M (+40.3%)
18.70M
est: 20.28M (-7.8%)
17.20M
est: 29.87M (-42.4%)
19.60M
est: 36.97M (-47.0%)
20.00M
est: 21.44M (-6.7%)
16.30M
est: 24.98M (-34.8%)
25.78M
25.17M – 26.30M
+3.2% YoY
27.87M
27.18M – 28.40M
+8.1% YoY
29.44M
28.73M – 30.01M
+5.6% YoY
EPS
-0.20
est: -0.35 (+42.8%)
-0.13
est: -0.40 (+67.9%)
-0.31
est: -0.33 (+4.9%)
-0.14
est: -0.12 (-17.5%)
-0.13
est: -0.12 (-4.4%)
-0.07
est: -0.05 (-24.0%)
0.01
est: 0.01 (-6.8%)
0.04
est: 0.02 (+89.6%)
0.03
est: 0.02 (+9.3%)
0.01
est: 0.03 (-69.6%)
0.02
est: 0.03 (-33.6%)
0.03
0.03 – 0.03
+24.5% YoY
0.04
0.03 – 0.04
+13.0% YoY
0.04
0.03 – 0.04
-2.1% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-04-22 B+ 3/5 5/5 3/5 5/5 2/5 1/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
32.54M
OE per share TTM
0.07
Owner's Yield
9.62%
Maintenance CapEx ratio
3.44%
Maint CapEx / Avg PPE
4.3%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
110.3K
Shares Outstanding
420.70M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Jonathan Emms Chief Executive Officer & Executive Director 1M male
Sarah Elizabeth Duncan Chief Financial Officer & Company Secretary 282.3K female
Tom Scaccia Senior Vice President of Americas & Research Business — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities